These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27770109)

  • 21. Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats.
    Reasor MJ; McCloud CM; Beard TL; Ebert DC; Kacew S; Gardner MF; Aldern KA; Hostetler KY
    Toxicology; 1996 Jan; 106(1-3):139-47. PubMed ID: 8571385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis.
    Lee JY; Han HJ; Lee SJ; Cho EH; Lee HB; Seok JH; Lim HS; Son WC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced phospholipidosis: are there functional consequences?
    Reasor MJ; Kacew S
    Exp Biol Med (Maywood); 2001 Oct; 226(9):825-30. PubMed ID: 11568304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-Based Imaging Assay for Detection of Phospholipidosis.
    Zhang L; Li S; Xia M
    Methods Mol Biol; 2022; 2474():73-82. PubMed ID: 35294757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J; Neville WA; Swain A; Miles A; Leonard MS; Waterfield CJ
    Biomarkers; 2004; 9(3):271-90. PubMed ID: 15764292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental phospholipidosis induced by 4,4'-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations.
    Tashiro Y; Watanabe Y; Enomoto Y
    Acta Pathol Jpn; 1983 Sep; 33(5):929-42. PubMed ID: 6316720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
    Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V
    Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations.
    Degott C; Messing B; Moreau D; Chazouillères O; Paris R; Colombel JF; Lebrec D; Potet F; Feldmann G; Benhamou JP
    Gastroenterology; 1988 Jul; 95(1):183-91. PubMed ID: 3131177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the role of endogenous opioid system in chloroquine-induced phospholipidosis in rat liver by morphological, biochemical and molecular modelling studies.
    Malek MR; Ahmadian S; Dehpour AR; Ebrahim-Habibi A; Shafizadeh M; Kashani-Amin E
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1575-1583. PubMed ID: 32367550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cationic amphiphilic drug-induced phospholipidosis.
    Halliwell WH
    Toxicol Pathol; 1997; 25(1):53-60. PubMed ID: 9061852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phospholipidosis induced by chlorimipramine in rat lung].
    Gremigni D; Vannelli G; Sgaragli GP; Mengazzini I
    Boll Soc Ital Biol Sper; 1980 May; 56(10):1078-82. PubMed ID: 7448010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting phospholipidosis using machine learning.
    Lowe R; Glen RC; Mitchell JB
    Mol Pharm; 2010 Oct; 7(5):1708-14. PubMed ID: 20799726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate.
    Cox JW; Ulrich RG; Wynalda MA; McKenna R; Larsen ER; Ginsberg LC; Epps DE
    Biochem Pharmacol; 1989 Oct; 38(20):3535-41. PubMed ID: 2530987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro validation of drug-induced phospholipidosis.
    Park S; Choi YJ; Lee BH
    J Toxicol Sci; 2012; 37(2):261-7. PubMed ID: 22467016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized p-phenylenediamine: observations on the staining reaction in epoxy embedded tissues.
    Armas-Portela R; Stockert JC; Ferrer JM; Tato A; Gómez-Perretta C; Callaghan RC
    Acta Histochem Suppl; 1986; 32():255-66. PubMed ID: 2422692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalized phospholipidosis induced by an amphiphilic cationic psychotropic drug.
    Robison RL; Visscher GE; Roberts SA; Engstrom RG; Hartman HA; Ballard FH
    Toxicol Pathol; 1985; 13(4):335-48. PubMed ID: 3834585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
    Kacew S
    J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities.
    Tengstrand EA; Miwa GT; Hsieh FY
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):555-70. PubMed ID: 20370598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.